Market Overview

Morgan Stanley: Medtronic's $4B Financing Could Be 10-Cent EPS Tailwind

Morgan Stanley: Medtronic's $4B Financing Could Be 10-Cent EPS Tailwind

Medtronic PLC (NYSE: MDT)’s announcement that it is commencing an offer for more than $4 billion in debt securities should help the company manage its tax headwind, according to Morgan Stanley. 

The Analyst

David Lewis maintained an Equal-weight rating on Medtronic with a $100 price target.

The Thesis

Medtronic announced Monday that it will commence an offer for up to $4.175 billion in outstanding debt securities; Lewis said the offer should be leverage neutral. (See his track record here.)

The financing could amount to as much as a 10-cent tailwind to EPS in fiscal 2020, or nearly 2% EPS growth if the company is able to complete the tender for the full amount, the analyst said. 

The medical device company's most recent guidance included $200 million to $210 million in quarterly interest expenses, Lewis said. The offer could bring interest below $175 million, boosting Medtronic's EPS, he said. 

“Management could also selectively reinvest some of these savings," the analyst said. 

Price Action

Medtronic shares were down 0.16% at $98.95 late in Tuesday's session. 

Related Links:

Wells Fargo: Medtronic An Accelerating Growth Story Trading At A Discount

The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut

Photo courtesy of Medtronic. 

Latest Ratings for MDT

Mar 2020Morgan StanleyMaintainsEqual-Weight
Mar 2020CitigroupMaintainsBuy
Mar 2020DZ BankUpgradesHoldBuy

View More Analyst Ratings for MDT
View the Latest Analyst Ratings


Related Articles (MDT)

View Comments and Join the Discussion!

Posted-In: Analyst Color Biotech News Health Care Financing Price Target Reiteration Analyst Ratings Best of Benzinga

Latest Ratings

RIGRF LaffertyMaintains5.0
NOVRF LaffertyMaintains13.0
WSCDA DavidsonMaintains19.0
ITTDA DavidsonReiterates70.0
NOWGoldman SachsMaintains376.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at